Connect your AI

Profound Medical PROF Price / sales

Price / sales at other companies

Intuitive SurgicalISRG

15.5×-4.9×

BioventusBVS

1.1×0.0×

Globus MedicalGMED

3.8×-0.3×

Other financials

Income statement

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

Profitability

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Calculated from Profound Medical’s reported figures.

market cap/total revenue=12.5×

Based on the most recent quarter.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Profound Medical's price / sales?: Profound Medical (PROF) reported price / sales of 12.5× in Q1 2026.
How has Profound Medical's price / sales changed year-over-year?: Profound Medical's price / sales decreased by 15.2% year-over-year, from 14.7× to 12.5×.
What is the long-term trend for Profound Medical's price / sales?: Over 2 years (2023 to 2025), Profound Medical's price / sales has grown at a -17.2% compound annual growth rate (CAGR), from 25.2× to 17.3×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.